J Korean Diabetes > Volume 20(2); 2019 > Article
The Journal of Korean Diabetes 2019;20(2):117-126.
DOI: https://doi.org/10.4093/jkd.2019.20.2.117    Published online July 17, 2019.
인슐린 사용에 제한을 가진 제2형 당뇨병 환자에서 경구혈당강하제 4제요법의 유용성
, , ,
1
2
Therapeutic Effect of Quadruple Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus Who Have Insulin Limitations.
Won Sang Yoo, Do Hee Kim, Hee Jin Kim, Hyun Kyung Chung
1Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea. chkendo@dankook.ac.kr
2Department of Kinesiologic Medical Science, Graduate School, Dankook University, Cheonan, Korea.
Abstract
BACKGROUND
Insulin therapy is the treatment of choice in type 2 diabetes mellitus (T2DM) patients who are not achieving glycemic goals despite triple oral hypoglycemic agent (OHA) combination therapy. However, there is still no additional treatment option for patients who cannot afford insulin therapy or who have various clinical limitations. The purpose of this study was to evaluate the clinical efficacy and safety of four OHA combination therapy in poorly controlled T2DM patients who could not afford insulin therapy. METHODS: Forty-seven T2DM patients were enrolled according to the following criteria: 1) glycosylated hemoglobin [HbA1c] > 8.5%, 2) ongoing treatment with 3 OHA combination therapy (metformin, sulfonylurea, dipeptidyl peptidase-4 inhibitor), or 3) combined limitations for applying insulin therapy. Patients were given the fourth OHA (pioglitazone) in addition to their previous treatment for 12 months. We evaluated changes in HbA1c, body weight, hypoglycemic events, and side effects. RESULTS: At study completion, mean HbA1c and fasting plasma glucose were significantly reduced from 9.6% to 8.04% and from 198.4 mg/dL to 161.5 mg/dL, respectively (P < 0.001). Mean body weight was significantly increased from 66.7 kg to 69.3 kg. Hypoglycemia and side effects were observed 18 times and only 3 cases showed abnormal liver function tests or edema. In addition, subjects with higher initial HbA1c levels and HOMA-beta showed an independent association with a greater reduction in HbA1c. CONCLUSION: The 4 OHA combination therapy is effective and safe when insulin is not feasible.
Key Words: Diabetes mellitus, type 2, Drug therapy, combination, Hypoglycemic agents


Editorial Office
101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-714-9064    Fax: +82-2-714-9084    E-mail: diabetes@kams.or.kr                

Copyright © 2022 by Korean Diabetes Association. All rights reserved.

Developed in M2PI

Close layer